Study Stopped
Study funding terminated prior to recruitment
Daily Egg Consumption and Cognitive Function in Older Adults
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to test the effects of provisioning twelve eggs weekly, incorporated into breakfast meals, on composite scores of executive functioning and memory using the CNSVS computerized test platform in older adults in a randomized study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedStudy Start
First participant enrolled
February 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2023
CompletedFebruary 28, 2023
February 1, 2023
Same day
July 12, 2022
February 24, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Composite Memory
Derived from the CNSVS verbal and visual memory test scores
12-week
Executive Function
Derived from Shifting Attention Test (SAT) from CNSVS battery of tests
12-week
Secondary Outcomes (7)
Verbal memory
12-week
Visual memory
12-week
Processing speed
12-week
Reaction time
12-week
Simple Attention
12-week
- +2 more secondary outcomes
Other Outcomes (10)
Dietary intakes
12-week
Physical performance
12-week
Serum total cholesterol
12-week
- +7 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTALParticipants randomized to the intervention group will receive six premade egg-containing breakfast meals per week in the form of a 3-day rotating menu. Each meal contains 2 eggs to provide 12 eggs per week for a duration of 12 weeks.
Control group
OTHERParticipants randomized to the control group will receive breakfast meals in the form of a 3-day rotating menu including typical foods found in American diets excluding eggs, e.g., corn flakes, milk, sausage, granola bars, fruit. Control recipes are matched to the intervention foods on total energy and saturated fat and to the 'What We Eat in America' on percent energy from macronutrients.
Interventions
Involves participants eating six premade egg-containing breakfast meals per week for 12 weeks. Each meal contains 2 eggs to provide 12 eggs per week.
Involves participants eating six premade egg-excluding breakfast meals per week for 12 weeks. Breakfast meals are matched to the intervention egg-containing breakfast meals on total energy and saturated fat and to the 'What We Eat in America' on percent energy from macronutrients.
Eligibility Criteria
You may qualify if:
- Participant has autonomy over their food choices.
- Participant has the common appliances for storing refrigerated and frozen foods (i.e., refrigerator and freezer).
- Participant has common appliances to defrost/prepare foods (e.g., microwave oven, oven, stove, etc.).
- Participant has sufficient corrected visual acuity to read simple instructions on a computer/laptop screen
- Participant has a CNSVS standard (age-matched) score of 85-105 (inclusive) for either the domain composite memory (raw score is the sum of verbal memory score and visual memory score) or the domain executive function, and 80-110 for the other.
- Participant has no plans to change their routine (physical activity pattern, dietary habits, sleep pattern, smoking habits) during the study period unless advised as part of study participation.
- Participant is willing to follow screening/assessment visit instructions.
- Participant is willing to consume the study foods as provided at the breakfast meals during the study period.
- Participant is willing and able to visit IUB campus on specified in-person visit days.
- Participant understands the study procedures and signs the informed consent to participate in the study and is willing to complete study procedures.
You may not qualify if:
- Participant is not fully vaccinated for COVID-19.
- Participant reports habitually consuming greater than 5.5 eggs per week.
- Participant has sensitivity, allergy, taste aversion, or other aversion (e.g., vegan) to any ingredient of the study food.
- Participant has substantial dietary restrictions (e.g., chronic kidney disease or familial hypercholesterolemia diet) that, based on the judgment of the Principal Investigator, would interfere with the intervention.
- Participant is under active chemotherapy treatment.
- Participant is participating in a parallel research study that, based on the judgment of the Principal Investigator, would interfere with his or her ability to comply with the study protocol, or which might confound the interpretation of the study results.
- Participant is not able to read.
- Participant reports current use of cognitive enhancing medications, attention/concentration enhancing medications, anticonvulsant medications, and mood stabilizing medications.
- Participant has a condition that, based on the judgment of the Principal Investigator, would interfere with his or her ability to provide informed consent or comply with the study protocol, or which might confound the interpretation of the study results or put the person at undue risk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- American Egg Boardcollaborator
Study Sites (1)
Indiana University-Bloomington
Bloomington, Indiana, 47401, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew W Brown, PhD
Indiana University, Bloomington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessments will be conducted before randomization at baseline and by individuals blinded to the treatment assignments at follow-up. Data will be analyzed prior to unblinding.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 12, 2022
First Posted
July 15, 2022
Study Start
February 10, 2023
Primary Completion
February 10, 2023
Study Completion
February 10, 2023
Last Updated
February 28, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Immediately
- Access Criteria
- Publicly available to anyone for the purpose of reproducing and/or verifying published results.
All deidentified data and statistical code used for publication of the study results will be accessible publicly for other researchers to be able to reproduce and/or verify published results after confirmation that deidentified data cannot be reasonably statistically re-identified.